Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 95 articles:
HTML format
Text format



Single Articles


    July 2017
  1. GANDHI JK, Roy Chowdhury U, Manzar Z, Buck J, et al
    Differential Intraocular Pressure Measurements by Tonometry and Direct Cannulation After Treatment with Soluble Adenylyl Cyclase Inhibitors.
    J Ocul Pharmacol Ther. 2017 Jul 7. doi: 10.1089/jop.2017.0027.
    PubMed     Text format     Abstract available


    June 2017
  2. VERHOEVEN RS, Garcia A, Robeson R, Gilger BC, et al
    Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
    J Ocul Pharmacol Ther. 2017 Jun 26. doi: 10.1089/jop.2016.0195.
    PubMed     Text format     Abstract available


  3. PATIL R, Wang H, Sharif NA, Mitra A, et al
    Aquaporins: Novel Targets for Age-Related Ocular Disorders.
    J Ocul Pharmacol Ther. 2017 Jun 20. doi: 10.1089/jop.2017.0024.
    PubMed     Text format     Abstract available


  4. LIN CW, Sherman B, Moore LA, Laethem CL, et al
    Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
    J Ocul Pharmacol Ther. 2017 Jun 13. doi: 10.1089/jop.2017.0023.
    PubMed     Text format     Abstract available



  5. Retraction of: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment; DOI: 10.1089/jop.2015.0099.
    J Ocul Pharmacol Ther. 2017 Jun 12. doi: 10.1089/jop.2015.0099.
    PubMed     Text format    


  6. MORI A, Yabuta C, Kishimoto Y, Kozai S, et al
    In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
    J Ocul Pharmacol Ther. 2017 Jun 9. doi: 10.1089/jop.2016.0136.
    PubMed     Text format     Abstract available


  7. KOC M, Bostanci B, Demirel OO, Genc F, et al
    The Effect of Ascorbic Acid (Vitamin C) on Transepithelial Corneal Cross-Linking in Rabbits.
    J Ocul Pharmacol Ther. 2017 Jun 7. doi: 10.1089/jop.2017.0025.
    PubMed     Text format     Abstract available


    May 2017
  8. GARWEG JG, Gerhardt C, Kodjikian L, Pfister IB, et al
    Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degeneration over 24 Months.
    J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0031.
    PubMed     Text format     Abstract available


  9. FABIANI C, Vitale A, Emmi G, Lopalco G, et al
    Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
    J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0034.
    PubMed     Text format     Abstract available


  10. WU YH, Wang LC, Yen SH, Yu WK, et al
    Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.
    J Ocul Pharmacol Ther. 2017 May 17. doi: 10.1089/jop.2016.0175.
    PubMed     Text format     Abstract available


  11. FRERE A, Caspers L, Makhoul D, Judice L, et al
    Single Dexamethasone Intravitreal Implant in the Treatment of Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2017;33:290-297.
    PubMed     Text format     Abstract available


  12. FOUSSAT A, Gregoire S, Clerget-Chossat N, Terrada C, et al
    Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
    J Ocul Pharmacol Ther. 2017;33:278-284.
    PubMed     Text format     Abstract available


    April 2017
  13. CHO HJ, Kim JM, Kim HS, Lee DW, et al
    Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Apr 26. doi: 10.1089/jop.2016.0178.
    PubMed     Text format     Abstract available


  14. SCHMIDL D, Werkmeister R, Kaya S, Unterhuber A, et al
    A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2017 Apr 25. doi: 10.1089/jop.2016.0123.
    PubMed     Text format     Abstract available


  15. ANTOUN J, Willermain F, Makhoul D, Motulsky E, et al
    Topical Ganciclovir in Cytomegalovirus Anterior Uveitis.
    J Ocul Pharmacol Ther. 2017 Apr 20. doi: 10.1089/jop.2016.0138.
    PubMed     Text format     Abstract available


  16. MOOSAJEE M, Ferguson V
    Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".
    J Ocul Pharmacol Ther. 2017 Apr 19. doi: 10.1089/jop.2017.29030.
    PubMed     Text format    


  17. ORAY M, Onal S, Uludag G, Koc Akbay A, et al
    Interferon Alpha for the Treatment of Cystoid Macular Edema Associated with Presumed Ocular Tuberculosis.
    J Ocul Pharmacol Ther. 2017 Apr 17. doi: 10.1089/jop.2016.0097.
    PubMed     Text format     Abstract available


  18. ZHANG P, Wang H, Cao H, Xu X, et al
    Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    J Ocul Pharmacol Ther. 2017 Apr 12. doi: 10.1089/jop.2016.0171.
    PubMed     Text format     Abstract available


  19. GONZALES JA, Haemel A, Gross AJ, Acharya NR, et al
    Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    J Ocul Pharmacol Ther. 2017 Apr 10. doi: 10.1089/jop.2016.0135.
    PubMed     Text format     Abstract available


  20. KIM JH, Chang YS, Lee DW, Kim CG, et al
    Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept.
    J Ocul Pharmacol Ther. 2017 Apr 6. doi: 10.1089/jop.2016.0098.
    PubMed     Text format     Abstract available


  21. ELBAY A, Ozdemir H, Koytak A, Melikov A, et al
    Intravitreal Dexamethasone Implant for Treatment of Serous Macular Detachment in Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2017 Apr 4. doi: 10.1089/jop.2016.0187.
    PubMed     Text format     Abstract available


  22. PERENYI K, Dienes L, Kornafeld A, Kovacs B, et al
    The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
    J Ocul Pharmacol Ther. 2017 Apr 4. doi: 10.1089/jop.2016.0194.
    PubMed     Text format     Abstract available


  23. FERNANDEZ-FERREIRO A, Santiago-Varela M, Gil-Martinez M, Gonzalez-Barcia M, et al
    In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.
    J Ocul Pharmacol Ther. 2017;33:202-209.
    PubMed     Text format     Abstract available


  24. GREENE WA, Burke TA, Kaini RR, Por ED, et al
    Polarized Secretion of Matrix Metalloproteinases and Their Inhibitors by Retinal Pigment Epithelium Derived from Induced Pluripotent Stem Cells During Wound Healing.
    J Ocul Pharmacol Ther. 2017;33:132-140.
    PubMed     Text format     Abstract available


    March 2017
  25. STEM MS, Todorich B, Faia LJ
    Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.
    J Ocul Pharmacol Ther. 2017 Mar 29. doi: 10.1089/jop.2016.0127.
    PubMed     Text format     Abstract available


  26. PORT AD, Orlin A, Kiss S, Patel S, et al
    Cytomegalovirus Retinitis: A Review.
    J Ocul Pharmacol Ther. 2017 Mar 29. doi: 10.1089/jop.2016.0140.
    PubMed     Text format     Abstract available


  27. HORI Y, Kageyama T, Sakamoto A, Shiba T, et al
    Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    J Ocul Pharmacol Ther. 2017 Mar 27. doi: 10.1089/jop.2016.0092.
    PubMed     Text format     Abstract available


  28. SCHAAP-FOGLER M, Bahar I, Rephaeli A, Dahbash M, et al
    Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse Model.
    J Ocul Pharmacol Ther. 2017 Mar 24. doi: 10.1089/jop.2016.0017.
    PubMed     Text format     Abstract available


  29. SCHNABOLK G, Beon MK, Tomlinson S, Rohrer B, et al
    New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
    J Ocul Pharmacol Ther. 2017 Mar 23. doi: 10.1089/jop.2016.0101.
    PubMed     Text format     Abstract available


  30. SMITH WM
    Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2017 Mar 13. doi: 10.1089/jop.2016.0155.
    PubMed     Text format     Abstract available


  31. GERY I
    Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.
    J Ocul Pharmacol Ther. 2017 Mar 7. doi: 10.1089/jop.2017.29027.
    PubMed     Text format    


  32. ASLANKURT M, Andi I, Cekic O
    Re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model" by Moosajee et al. (J. Ocul. Pharmacol. Ther. 32:469-475, 2016).
    J Ocul Pharmacol Ther. 2017 Mar 6. doi: 10.1089/jop.2016.0183.
    PubMed     Text format    


  33. GOMES RL, Viana RG, Melo LA Jr, Cruz AC, et al
    Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1.
    J Ocul Pharmacol Ther. 2017;33:98-102.
    PubMed     Text format     Abstract available


    February 2017
  34. PATIL A, Majumdar S
    Echinocandins in Ocular Therapeutics.
    J Ocul Pharmacol Ther. 2017 Feb 24. doi: 10.1089/jop.2016.0186.
    PubMed     Text format     Abstract available


  35. STAHL E, Bremond-Gignac D, Landry T, Curtis M, et al
    Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma.
    J Ocul Pharmacol Ther. 2017 Feb 24. doi: 10.1089/jop.2016.0133.
    PubMed     Text format     Abstract available


  36. KOZAK I, Shoughy SS, Stone DU
    Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review.
    J Ocul Pharmacol Ther. 2017 Feb 6. doi: 10.1089/jop.2016.0118.
    PubMed     Text format     Abstract available


  37. YAMADA H, Yoneda M, Inaguma S, Gosho M, et al
    A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis.
    J Ocul Pharmacol Ther. 2017 Feb 3. doi: 10.1089/jop.2016.0085.
    PubMed     Text format     Abstract available


  38. KUO DE, Wei MM, Armbrust KR, Knickelbein JE, et al
    Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 Levels.
    J Ocul Pharmacol Ther. 2017 Feb 3. doi: 10.1089/jop.2016.0132.
    PubMed     Text format     Abstract available


    January 2017
  39. SEIBOLD LK, DeWitt PE, Kroehl ME, Kahook MY, et al
    The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    J Ocul Pharmacol Ther. 2017 Jan 27. doi: 10.1089/jop.2016.0141.
    PubMed     Text format     Abstract available


  40. BRANSON SV, McClafferty BR, Kurup SK
    Vitrectomy for Epiretinal Membranes and Macular Holes in Uveitis Patients.
    J Ocul Pharmacol Ther. 2017 Jan 23. doi: 10.1089/jop.2016.0142.
    PubMed     Text format     Abstract available


  41. CHEN H, Lin H, Chen W, Zhang B, et al
    Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E2 Inhibition in Femtosecond Laser-Assisted Cataract Surgery.
    J Ocul Pharmacol Ther. 2017 Jan 20. doi: 10.1089/jop.2016.0114.
    PubMed     Text format     Abstract available


  42. REVIGLIO VE, Osaba M, Sambuelli G, Kuo IC, et al
    Phototoxic Effect of Topical Fluoroquinolones Administered Before Corneal Crosslinking in a Murine Model.
    J Ocul Pharmacol Ther. 2017 Jan 20. doi: 10.1089/jop.2016.0060.
    PubMed     Text format     Abstract available


  43. ROBINSON J, Okoro E, Ezuedu C, Bush L, et al
    Effects of Hydrogen Sulfide-Releasing Compounds on Aqueous Humor Outflow Facility in Porcine Ocular Anterior Segments, Ex Vivo.
    J Ocul Pharmacol Ther. 2017 Jan 18. doi: 10.1089/jop.2016.0037.
    PubMed     Text format     Abstract available


  44. LIU S, Matsuo T, Hosoya O, Uchida T, et al
    Photoelectric Dye Used for Okayama University-Type Retinal Prosthesis Reduces the Apoptosis of Photoreceptor Cells.
    J Ocul Pharmacol Ther. 2017 Jan 13. doi: 10.1089/jop.2016.0093.
    PubMed     Text format     Abstract available


  45. WANG JW, Vu C, Poloso NJ
    A Prostacyclin Analog, Cicaprost, Exhibits Potent Anti-Inflammatory Activity in Human Primary Immune Cells and a Uveitis Model.
    J Ocul Pharmacol Ther. 2017 Jan 10. doi: 10.1089/jop.2016.0167.
    PubMed     Text format     Abstract available


  46. FUCHS H, Igney F
    Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies.
    J Ocul Pharmacol Ther. 2017 Jan 5. doi: 10.1089/jop.2016.0083.
    PubMed     Text format     Abstract available


  47. BATTAGLIA PARODI M, Donati S, Semeraro F, Danzi P, et al
    Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice.
    J Ocul Pharmacol Ther. 2017 Jan 3. doi: 10.1089/jop.2016.0091.
    PubMed     Text format     Abstract available


    December 2016
  48. TABUCHI N, Toshida H, Koike D, Odaka A, et al
    Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
    J Ocul Pharmacol Ther. 2016 Dec 23. doi: 10.1089/jop.2015.0161.
    PubMed     Text format     Abstract available


  49. GUO J, Luo X, Liang J, Xiao M, et al
    Antiangiogenic Effects of Doxazosin on Experimental Choroidal Neovascularization in Mice.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  50. LIANG IC, Lin YR, Chien HW, Liu KR, et al
    Vision Preservation in Eyes of Polypoidal Choroidal Vasculopathy with Low-Dose Intravitreal Triamcinolone Acetonide.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  51. HERBORT CP JR, Tugal-Tutkun I, Neri P, Pavesio C, et al
    Failure to Integrate Quantitative Measurement Methods of Ocular Inflammation Hampers Clinical Practice and Trials on New Therapies for Posterior Uveitis.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  52. KOBASHI H, Kamiya K, Shimizu K
    Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  53. SUZUKI T, Yamamoto T, Torikai T, Ohashi Y, et al
    Combination Effect of Cefuroxime and Levofloxacin Against Bacteria Isolated from the Healthy Conjunctival Sac and Endophthalmitis Cases Using a Fractional Inhibitory Concentration Index.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available



  54. Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:355-364.
    J Ocul Pharmacol Ther. 2016;32:695.
    PubMed     Text format    



  55. Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:606-622.
    J Ocul Pharmacol Ther. 2016;32:695.
    PubMed     Text format    


    November 2016
  56. SENGUL EA, Artunay O, Turkseven Kumral E, Yenerel M, et al
    Retinal Nerve Fiber Layer Thickness Changes in Age-Related Macular Degeneration Treated with Multiple Intravitreal Ranibizumab.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  57. SENTHILKUMARI S, Sharmila R, Chidambaranathan G, Vanniarajan A, et al
    Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  58. YOO R, Choi YA, Cho BJ
    Change in Central Corneal Thickness After the Discontinuation of Latanoprost in Normal Tension Glaucoma-Change in Central Corneal Thickness After Stop of Latanoprost.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  59. KANG S, Choi H, Rho CR
    Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    October 2016
  60. JENSEN RJ
    Effects of Antipsychotic Drugs Haloperidol and Clozapine on Visual Responses of Retinal Ganglion Cells in a Rat Model of Retinitis Pigmentosa.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  61. WOODWARD DF, Wenthur SL, Rudebush TL, Fan S, et al
    Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  62. MANNA S, Augsburger JJ, Correa ZM, Al-Rjoub MF, et al
    Noninvasive Electroretinography Assessment of Intravitreal Sustained-Release Methotrexate Microimplants in Rabbit Eyes.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  63. YASUDA K, Motohashi R, Kotake O, Nakagawa H, et al
    Comparative Effects of Topical Diclofenac and Betamethasone on Inflammation After Vitrectomy and Cataract Surgery in Various Vitreoretinal Diseases.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  64. BECKEL JM, Lu W, Civan MM, Mitchell CH, et al
    Treatment of Retinal Disorders with Purinergic Drugs: Beyond Receptors.
    J Ocul Pharmacol Ther. 2016;32:488-489.
    PubMed     Text format    


    September 2016
  65. MINNS MS, Trinkaus-Randall V
    Purinergic Signaling in Corneal Wound Healing: A Tale of 2 Receptors.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  66. REED K, Li A, Wilson B, Assamoi T, et al
    Enhancement of Ocular In Situ Gelling Properties of Low Acyl Gellan Gum by Use of Ion Exchange.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    August 2016
  67. JACOBSON KA, Civan MM
    Ocular Purine Receptors as Drug Targets in the Eye.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  68. POR ED, Greene WA, Burke TA, Wang HC, et al
    Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  69. GARWEG JG, Baglivo E, Freiberg FJ, Pfau M, et al
    Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex).
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  70. KIM JH, Chang YS, Kim JW, Kim CG, et al
    Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    July 2016
  71. ISOBE T, Kasai T, Kawai H
    Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  72. BUI DK, Carvounis PE
    Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  73. HUANG JM, Pansick AD, Blomquist PH
    Use of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe Injury.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  74. SHIN KH, Kim JH, Cho SW, Lee TG, et al
    Efficacy of Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy in Patients Who Had Previously Responded Well to the Same Therapy.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  75. GARAY-ARAMBURU G, Gomez-Moreno A
    Response #2 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagoz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.
    J Ocul Pharmacol Ther. 2016;32:344-5.
    PubMed     Text format    


    June 2016
  76. GERBER WM, Meyer D, Smit DP
    Ocular and Cerebrospinal Fluid Penetration of Antiretroviral Agents.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  77. MOOSAJEE M, Tracey-White D, Harbottle RP, Ferguson V, et al
    Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  78. JEON HS, Hyon JY
    The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjogren and Sjogren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  79. SAKATA R, Sakisaka T, Matsuo H, Miyata K, et al
    Effect of Travoprost and Nonsteroidal Anti-Inflammatory Drug on Diurnal Intraocular Pressure in Normal Subjects with Low-Teen Baseline Intraocular Pressure.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  80. QUERQUES G, Darvizeh F, Querques L, Capuano V, et al
    Assessment of the Real-Life Usage of Intravitreal Dexamethasone Implant in the Treatment of Chronic Diabetic Macular Edema in France.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  81. TORIS CB, McLaughlin MA, Dworak DP, Fan S, et al
    Effects of Rho Kinase Inhibitors on Intraocular Pressure and Aqueous Humor Dynamics in Nonhuman Primates and Rabbits.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  82. MAH FS
    Effect on Gel Formation Time of Adding Topical Ophthalmic Medications to ReSure Sealant, an In Situ Hydrogel.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    May 2016
  83. KIKUSHIMA W, Sakurada Y, Sugiyama A, Tanabe N, et al
    Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  84. JOSHI R, Mankowski W, Winter M, Saini JS, et al
    Automated Measurement of Cobblestone Morphology for Characterizing Stem Cell Derived Retinal Pigment Epithelial Cell Cultures.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  85. YUN H, Zhou Y, Wills A, Du Y, et al
    Stem Cells in the Trabecular Meshwork for Regulating Intraocular Pressure.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  86. LEACH LL, Croze RH, Hu Q, Nadar VP, et al
    Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    April 2016
  87. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:133-4.
    PubMed     Text format    


  88. BANSAL P, Garg S, Sharma Y, Venkatesh P, et al
    Posterior Segment Drug Delivery Devices: Current and Novel Therapies in Development.
    J Ocul Pharmacol Ther. 2016;32:135-44.
    PubMed     Text format     Abstract available


    March 2016
  89. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:65-6.
    PubMed     Text format    


    January 2016
  90. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:1-2.
    PubMed     Text format    


  91. MCKAY BS, Schwartz SG
    Pigmentation and Macular Degeneration: Is There a Role for GPR143?
    J Ocul Pharmacol Ther. 2016;32:3-4.
    PubMed     Text format    


  92. CUCHACOVICH M, Solanes F, Perez C, Verdaguer JI, et al
    Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    J Ocul Pharmacol Ther. 2016;32:55-61.
    PubMed     Text format     Abstract available


  93. LINARES-ALBA MA, Gomez-Guajardo MB, Fonzar JF, Brooks DE, et al
    Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.
    J Ocul Pharmacol Ther. 2016;32:11-22.
    PubMed     Text format     Abstract available


  94. KOWALSKI RP, Romanowski EG, Yates KA, Mah FS, et al
    An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infective.
    J Ocul Pharmacol Ther. 2016;32:23-7.
    PubMed     Text format     Abstract available


  95. WATANABE A, Tsuzuki A, Arai K, Gekka T, et al
    Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
    J Ocul Pharmacol Ther. 2016;32:38-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: